Senate bill weighs on Allergan, Medicis

Allergan and Medicis Pharmaceutical Corp. lead drug stocks lower in morning activity as shares of the dermatology-products makers fall on news that the health-care reform bill put forth by Senate Democrats would levy a 5% tax on elective cosmetic procedures.